文献速递睡眠呼吸障碍

环路增益预测持续气道正压通气治疗下的残余睡眠呼吸暂停

Loop gain predicts residual sleep apnoea among people using positive airway pressure.
PubMed 文献 · Thorax · 2026-06-15

本研究基于APPLES和RICCADSA两项随机对照试验,评估基线高环路增益(LG)与持续气道正压通气(PAP)治疗下残余睡眠呼吸暂停的关联。基线通气控制不稳定可能是残余睡眠呼吸暂停的重要危险因素。

要点

  • 基线高环路增益与PAP治疗下残余睡眠呼吸暂停风险增加独立相关。
  • 校正混杂因素后,APPLES和RICCADSA中高LG的OR分别为2.17和3.31。
  • 基线通气控制不稳定或需更密切监测或辅助治疗以降低LG。

核心结论

  • 高环路增益是PAP治疗下残余睡眠呼吸暂停的显著危险因素。
  • 基线识别的通气控制不稳定可能需更密切监测或启动降低LG的辅助治疗。

研究设计与样本

  • 基于APPLES和RICCADSA两项大型随机对照试验的二次分析。
  • 基线多导睡眠图估算LG,残余睡眠呼吸暂停在APPLES用2个月PAP下多导睡眠图定义,在RICCADSA用3个月设备下载定义。
  • 采用逻辑回归估计最高四分位LG与残余睡眠呼吸暂停的比值比,并校正混杂因素;另用线性回归进行敏感性分析。

主要发现

  • 未校正分析中,高LG与残余睡眠呼吸暂停的比值比约为三倍,两个样本一致。
  • 考虑中枢性睡眠呼吸暂停指标后关联仍存在;线性回归证实LG与残余AHI相关。

关键数值与推荐

  • 残余睡眠呼吸暂停定义为呼吸暂停低通气指数≥10次/小时。
  • 高LG定义为最高四分位。
  • APPLES中残余睡眠呼吸暂停在2个月PAP治疗下用多导睡眠图评估;RICCADSA在3个月时用设备下载评估。

临床怎么用

  • 对PAP治疗患者可考虑基线LG评估以识别残余睡眠呼吸暂停高风险者。
  • 高LG患者可能需要更密切监测或辅助治疗以降低LG并改善治疗反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Residual sleep apnoea-defined by an Apnoea-Hypopnoea Index ≥10 events/hour-affects~20% of obstructive sleep apnoea patients treated with positive airway pressure therapy and poses a major clinical challenge. Ventilatory control instability is a plausible cause of residual sleep apnoea. Elevated loop gain (LG), a measure of ventilatory instability, may be a risk factor, but this has not been rigorously tested. OBJECTIVE: To assess whether high LG at baseline is associated with residual sleep apnoea on positive airway pressure therapy in two large, randomised control trials: Apnoea Positive Pressure Long-Term Efficacy Study (APPLES) and Randomised Intervention with CPAP in Coronary Artery Disease and OSA (RICCADSA). METHODS: LG was estimated from baseline polysomnography using a validated method. Residual sleep apnoea was defined using polysomnography on positive airway pressure at 2 months (APPLES) or device downloads at 3 months (RICCADSA). Logistic regression estimated the odds of residual sleep apnoea with high LG (highest quartile), adjusting for confounders. A sensitivity analysis was performed using linear regression, where both the exposure and outcome were defined continuously. MEASUREMENTS AND MAIN RESULTS: In the unadjusted analysis, high LG was associated with threefold odds of residual sleep apnoea in both samples. After adjustment, elevated odds persisted in both APPLES (2.17 (1.24-3.78)) and RICCADSA (3.31 (1.33-8.24)). Associations remained after accounting for measures of central sleep apnoea. Linear regression confirmed the association of LG and residual Apnoea-Hypopnoea Index. CONCLUSIONS: High LG is a significant risk factor for residual sleep apnoea on positive airway pressure therapy. Ventilatory control instability identified at baseline may warrant closer monitoring or the initiation of adjunctive therapies aimed at reducing LG and improving the therapeutic response.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Eschbach E, Kushida C, Peker Y, et al. Loop gain predicts residual sleep apnoea among people using positive airway pressure. Thorax. 2026. PMID: 41741209. doi:10.1136/thorax-2025-223878

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。